Anson Adds Manufacturing & Preclinical Experts

Anson Adds Manufacturing & Preclinical Experts, Broadens Pharma/Biologic Portfolio

Anson Group announces the addition of regulatory industry experts Steve Snyder and Steve Stilwell, RPh, to our panel of pharmaceutical and biologic consultants.

Steve Snyder: Steve Snyder has over 28 years of laboratory and management experience in preclinical toxicology at several major pharmaceutical companies. He has a demonstrated history of regulatory compliance and developing preclinical outsourcing strategies and has current established networks with outsourcing providers, outsourcing professionals and consultants representing diverse disciplines. Steve's history includes serving as the Animal Studies Head (Toxicology Division) at Eli Lilly & Company where he provided leadership for all scientific, regulatory, and administrative activities.

Steve Stillwell, RPh: Steve Stilwell has an extensive background in cGMP manufacturing compliance that encompasses parenteral, sterile bulk API, liquid, and ointment items. His 30+ years experience includes serving as a Senior Quality Assurance Representative for over 22 years in which he provided quality assurance support and oversight. He has also developed and implemented product complaint and supplier classification and auditing procedures, validation protocols, and cGMP training programs. Additional experience also includes over six years of providing support for the various aspects of clinical research studies.